YOU ARE
A SPONSOR / CRO
Success is when the time to access an innovative treatment is reduced.
Get more informationsOptimize patient recruitment for your clinical trials
By providing CT-SCOUT™ to your clinical sites you will both facilitate their contribution to your studies and get a better overview of the site recruitment activities for your studies. You can also further enlarge your patient reach by providing ToTem4me to referral sites, with no need to train them on your studies.
THE PATIENT JOURNEY
Telemedicine Technologies favors direct contact with patients (with the medical team via ct-scout) and (with an expert clinical trial coordinator via ToTem4me) to involve them wherever they are and empower them to make the decision to participate in a clinical trial.
Through a questionnaire based on a powerful and reliable algorithm, you can pre-select qualified patients for your trial.
A coordinator is made available to the patient following registration on ToTem4me to follow up with the patient before, during and after inclusion in a clinical trial. A notification is sent to the clinical research team once a pest has been detected on CT-SCOUT™.
Looking for innovative digital solutions to optimize patient recruitment in IBD trials
Read the postTestimonials
« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,
« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »
« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,
LATEST NEWSOUR NEWS >
September 30, 2024
29 October 2024 from 10:00AM to 11:30AM (CET) Register Now! Overview Clinical stage is the most expensive stage of drug development. The cost of clinical trials has increased by 100% over the past decade. It is natural, that it should be approached with careful planning and understanding of the rationale behind each item of the […]
September 30, 2024
Applied Clinical Trials Online As the field of clinical research undergoes rapid evolution, so too must the methodologies employed to safeguard patient participants. Whereas the focus of recent decades was predominantly on developing novel cardiovascular treatments for heart disease, contemporary research increasingly targets innovative therapies for conditions such as Alzheimer’s disease, cancer, and rare disorders. […]
September 30, 2024
Med City News Artificial intelligence (AI) holds potential to forecast and predict where hospital leaders should direct limited resources such as clinicians, staff, and beds to improve operational efficiency and drive better patient outcomes. Although health systems have seen some much-needed improvement to operating margins in recent quarters, these positive headlines mask a disturbing reality […]